This page in English

Anna Göthlin-Eremo

Tjänstetitel: Universitetslektor, adjungerad Organisation: Institutionen för medicinska vetenskaper

E-post:

Telefon: 019 303000 (växel)

Rum: C3113

Anna Göthlin-Eremo

Forskningsämne

Publikationer

Artiklar i tidskrifter |  Doktorsavhandlingar, sammanläggningar |  Manuskript | 

Artiklar i tidskrifter

Göthlin Eremo, A. , Lagergren, K. , Othman, L. , Montgomery, S. , Andersson, G. & Tina, E. (2020). Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer. Scientific Reports, 10 (1).
Paramel Varghese, G. , Karadimou, G. , Göthlin Eremo, A. , Ljungberg, L. , Hedin, U. , Olofsson, P. S. , Folkersen, L. , Paulsson Berne, G. & et al. (2020). Expression of CARD8 in human atherosclerosis and its regulation of inflammatory proteins in human endothelial cells. Scientific Reports, 10 (1).
Bergemalm, D. , Ramström, S. , Kardeby, C. , Hultenby, K. , Göthlin Eremo, A. , Sihlbom, C. , Bergström, J. , Palmblad, J. & et al. (2020). Platelet proteome and function in X-linked thrombocytopenia with thalassemia and in silico comparisons with gray platelet syndrome. Haematologica.
Tina, E. , Prosén, S. , Lennholm, S. , Gasparyan, G. , Lindberg, M. & Göthlin Eremo, A. (2019). Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma. British Journal of Dermatology, 180 (1), 130-140.
Prosén, S. , Göthlin Eremo, A. , Tsegai, A. D. , Lindberg, M. & Tina, E. (2017). Decreased expression of the mitochondrial solute carrier SLC25A43 in basal cell carcinoma compared with healthy skin. Oncology Letters, 14 (2), 2218-2222.
Göthlin Eremo, A. , Tina, E. , Wegman, P. , Stål, O. , Fransén, K. , Fornander, T. & Wingren, S. (2015). HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen. International Journal of Oncology, 47 (4), 1311-1320.
Göthlin Eremo, A. , Wegman, P. , Stål, O. , Nordenskjöld, B. , Fornander, T. & Wingren, S. (2013). Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients. Oncology Reports, 29 (4), 1467-1474.
Wegman, P. , Göthlin Eremo, A. , Lindlöf, A. , Karlsson, M. G. , Stål, O. & Wingren, S. (2011). Expression of the forkhead transcription factor FOXL2 correlates with good prognosis in breast cancer patients treated with tamoxifen. International Journal of Oncology, 38 (4), 1145-1151.

Doktorsavhandlingar, sammanläggningar

Göthlin Eremo, A. (2015). Biological profiles of endocrine breast cancer. (Doctoral dissertation). (Sammanläggning) Örebro: Örebro university.

Manuskript

Paramel Varghese, G. , Göthlin Eremo, A. , Ljungberg, L. , Sirsjö, A. & Fransén, K. CARD8, a protein of innate immunity regulates the release of inflammatory cytokines in human endothelial cells.
Göthlin Eremo, A. , Tina, E. , Kruse, R. , Fransén, K. , Wegman, P. , Repsilber, D. , Montgomery, S. , Sollie, T. & et al. Gene expression profiles in breast tumors from tamoxifen treated patients with and without distant recurrence.
Göthlin Eremo, A. , Tina, E. , Wegman, P. , Stål, O. , Fransén, K. , Fornander, T. & Wingren, S. HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen.
Gabrielson, M. , Göthlin Eremo, A. , Tina, E. , Karlsson, E. , Jakobsson, F. , Stål, O. & Wingren, S. Regulation of cell proliferation and recurrence-free survival in HER2-positive breast cancer through SLC25A43 and p27.